Correlation Between Aldeyra and Vaxxinity
Can any of the company-specific risk be diversified away by investing in both Aldeyra and Vaxxinity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and Vaxxinity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldeyra and Vaxxinity, you can compare the effects of market volatilities on Aldeyra and Vaxxinity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of Vaxxinity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and Vaxxinity.
Diversification Opportunities for Aldeyra and Vaxxinity
Pay attention - limited upside
The 3 months correlation between Aldeyra and Vaxxinity is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and Vaxxinity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxxinity and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with Vaxxinity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxxinity has no effect on the direction of Aldeyra i.e., Aldeyra and Vaxxinity go up and down completely randomly.
Pair Corralation between Aldeyra and Vaxxinity
Given the investment horizon of 90 days Aldeyra is expected to generate 1.12 times less return on investment than Vaxxinity. In addition to that, Aldeyra is 1.15 times more volatile than Vaxxinity. It trades about 0.03 of its total potential returns per unit of risk. Vaxxinity is currently generating about 0.04 per unit of volatility. If you would invest 250.00 in Vaxxinity on November 2, 2024 and sell it today you would earn a total of 22.00 from holding Vaxxinity or generate 8.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.47% |
| Values | Daily Returns |
Aldeyra vs. Vaxxinity
Performance |
| Timeline |
| Aldeyra |
| Vaxxinity |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aldeyra and Vaxxinity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aldeyra and Vaxxinity
The main advantage of trading using opposite Aldeyra and Vaxxinity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, Vaxxinity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxxinity will offset losses from the drop in Vaxxinity's long position.| Aldeyra vs. Tarsus Pharmaceuticals | Aldeyra vs. Travere Therapeutics | Aldeyra vs. Eton Pharmaceuticals | Aldeyra vs. Viridian Therapeutics |
| Vaxxinity vs. Tarsus Pharmaceuticals | Vaxxinity vs. Aldeyra | Vaxxinity vs. Travere Therapeutics | Vaxxinity vs. Eton Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |